3-hydroxy-3-methylglutaryl-coenzyme a has been researched along with Disease Exacerbation in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adigun, R; Asleh, R; Boilson, BA; Briasoulis, A; Daly, RC; Edwards, BS; Kushwaha, SS; Lerman, A; Maltais, S; Pereira, NL | 1 |
1 other study(ies) available for 3-hydroxy-3-methylglutaryl-coenzyme a and Disease Exacerbation
Article | Year |
---|---|
Timing of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor initiation and allograft vasculopathy progression and outcomes in heart transplant recipients.
Topics: Acyl Coenzyme A; Allografts; Biopsy; Coronary Vessels; Disease Progression; Drug Administration Schedule; Female; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Prognosis; Retrospective Studies; Time Factors; Time-to-Treatment; Ultrasonography, Interventional; Vascular Diseases | 2018 |